Resistentia Pharmaceuticals AB

Desentum

This biopharmaceutical company develops allergen immunotherapy products to treat patients suffering from respiratory and food allergies.

RSPR Pharma AB

The company develops oral therapies for respiratory and cardiovascular diseases, targeting patients with uncontrolled asthma and rare conditions.

Pharmexa A/S

This company develops active immunotherapy and peptide vaccines for patients with cancer, chronic illnesses, and infectious diseases.

Connect Biopharma

This clinical-stage biopharmaceutical company develops immune-modulating therapies for patients suffering from asthma and chronic obstructive pulmonary disease.

Allegria therapeutics

This company develops therapeutic treatments that modulate mast cell activity for patients suffering from allergic and inflammatory diseases.

Areteia Therapeutics

The company develops an oral medication for patients with eosinophilic asthma to reduce inflammation and manage their condition.

Aiolos Bio

This biopharmaceutical company develops monoclonal antibody therapies for patients suffering from respiratory and inflammatory conditions such as moderate-to-severe asthma.

Kinaset Therapeutics

This biopharmaceutical company develops inhaled anti-inflammatory therapies to treat patients with severe asthma and other respiratory diseases.